Leukocytes and systemic inflammatory response syndrome as prognostic factors in pulmonary embolism patients

BMC Pulmonary Medicine

Volumn 13, Issue 1, 2013, Pages

  Jo, Jun Y ^a   Lee, Mi Y ^a   Lee, Jin W ^a   Rho, Byung H ^a   Choi, Won Il ^a  

^a Keimyung University School of Medicine   (South Korea)

Author keywords

Leukocytosis; Pulmonary embolism; Systemic inflammatory response syndrome

Indexed keywords

AGED; ARTICLE; BODY TEMPERATURE; BREATHING RATE; COHORT ANALYSIS; DISEASE SEVERITY; FEMALE; HEART LEFT VENTRICLE SIZE; HEART RATE; HEART RIGHT VENTRICLE; HEART VENTRICLE SIZE; HUMAN; INFECTION; KIDNEY DYSFUNCTION; LEUKOCYTE; LEUKOCYTE COUNT; LEUKOCYTOSIS; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MORTALITY; NEOPLASM; PREDICTIVE VALUE; PREDICTOR VARIABLE; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; SHOCK; SHORT TERM SURVIVAL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

AGED; AGED, 80 AND OVER; AREA UNDER CURVE; BODY TEMPERATURE; FEMALE; HEART RATE; HEART VENTRICLES; HUMANS; LEUKOCYTE COUNT; LEUKOCYTES; LEUKOCYTOSIS; MALE; MENTAL DISORDERS; MIDDLE AGED; MODELS, BIOLOGICAL; PROGNOSIS; PULMONARY EMBOLISM; RESPIRATORY RATE; RETROSPECTIVE STUDIES; ROC CURVE; SEVERITY OF ILLNESS INDEX; SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84889823639     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-13-74     Document Type: Article

References (32)

1. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999, 353:1386-1389. 10.1016/S0140-6736(98)07534-5, 10227218.
2. Donze J, Le Gal G, Fine MJ, Roy PM, Sanchez O, Verschuren F, Cornuz J, Meyer G, Perrier A, Righini M, Aujesky D. Prospective validation of the pulmonary embolism severity index. A clinical prognostic model for pulmonary embolism. Thromb Haemost 2008, 100:943-948.
3. Kucher N, Goldhaber SZ. Cardiac biomarkers for risk stratification of patients with acute pulmonary embolism. Circulation 2003, 108:2191-2194. 10.1161/01.CIR.0000100687.99687.CE, 14597581.
4. Aujesky D, Obrosky DS, Stone RA, Auble TE, Perrier A, Cornuz J, Roy PM, Fine MJ. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med 2005, 172:1041-1046. 10.1164/rccm.200506-862OC, 2718410, 16020800.
5. Agnelli G, Becattini C. Acute pulmonary embolism. N Engl J Med 2010, 363:266-274. 10.1056/NEJMra0907731, 20592294.
6. Bova C, Pesavento R, Marchiori A, Palla A, Enea I, Pengo V, Visona A, Noto A, Prandoni P. Risk stratification and outcomes in hemodynamically stable patients with acute pulmonary embolism: a prospective, multicentre, cohort study with three months of follow-up. J Thromb Haemost 2009, 7:938-944. 10.1111/j.1538-7836.2009.03345.x, 19302447.
7. Jimenez D, Diaz G, Molina J, Marti D, Del Rey J, Garcia-Rull S, Escobar C, Vidal R, Sueiro A, Yusen RD. Troponin I and risk stratification of patients with acute nonmassive pulmonary embolism. Eur Respir J 2008, 31:847-853. 10.1183/09031936.00113307, 18094010.
8. Bagot CN, Arya R. Virchow and his triad: a question of attribution. Br J Haematol 2008, 143:180-190. 10.1111/j.1365-2141.2008.07323.x, 18783400.
9. Smeeth L, Cook C, Thomas S, Hall AJ, Hubbard R, Vallance P. Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet 2006, 367:1075-1079. 10.1016/S0140-6736(06)68474-2, 16581406.
10. van Wissen M, Keller TT, Ronkes B, Gerdes VE, Zaaijer HL, van Gorp EC, Brandjes DP, Levi M, Buller HR. Influenza infection and risk of acute pulmonary embolism. Thromb J 2007, 5:16. 10.1186/1477-9560-5-16, 2104525, 17939867.
11. Del Borgo C, Gianfreda R, Belvisi V, Citton R, Soscia F, Notarianni E, Tieghi T, Mastroianni CM. Pulmonary embolism and acute cytomegalovirus infection in an immunocompetent patient. Infez Med 2010, 18:270-272.
12. Aue G, Nelson Lozier J, Tian X, Cullinane AM, Soto S, Samsel L, McCoy P, Wiestner A. Inflammation, TNFalpha and endothelial dysfunction link lenalidomide to venous thrombosis in chronic lymphocytic leukemia. Am J Hematol 2011, 86:835-840. 10.1002/ajh.22114, 3414537, 21812019.
13. Jezovnik MK, Poredos P. Idiopathic venous thrombosis is related to systemic inflammatory response and to increased levels of circulating markers of endothelial dysfunction. Int Angiol 2010, 29:226-231.
14. Bucek RA, Reiter M, Quehenberger P, Minar E. C-reactive protein in the diagnosis of deep vein thrombosis. Br J Haematol 2002, 119:385-389. 10.1046/j.1365-2141.2002.03886.x, 12406073.
15. Jimenez D, Aujesky D, Moores L, Gomez V, Lobo JL, Uresandi F, Otero R, Monreal M, Muriel A, Yusen RD. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med 2010, 170:1383-1389. 10.1001/archinternmed.2010.199, 20696966.
16. Charkes ND, Dugan MA, Malmud LS, Stern H, Anderson H, Kozar J, Maguire R. Letter: labelled leucocytes in thrombi. Lancet 1974, 2:600.
17. Stewart GJ, Ritchie WG, Lynch PR. Venous endothelial damage produced by massive sticking and emigration of leukocytes. Am J Pathol 1974, 74:507-532. 1910801, 4814899.
18. Myers DD, Hawley AE, Farris DM, Chapman AM, Wrobleski SK, Henke PK, Wakefield TW. Cellular IL-10 is more effective than viral IL-10 in decreasing venous thrombosis. J Surg Res 2003, 112:168-174. 10.1016/S0022-4804(03)00144-6, 12888334.
19. van der Meer RW, Pattynama PM, van Strijen MJ, van den Berg-Huijsmans AA, Hartmann IJ, Putter H, de Roos A, Huisman MV. Right ventricular dysfunction and pulmonary obstruction index at helical CT: prediction of clinical outcome during 3-month follow-up in patients with acute pulmonary embolism. Radiology 2005, 235:798-803. 10.1148/radiol.2353040593, 15845793.
20. Ghuysen A, Ghaye B, Willems V, Lambermont B, Gerard P, Dondelinger RF, D'Orio V. Computed tomographic pulmonary angiography and prognostic significance in patients with acute pulmonary embolism. Thorax 2005, 60:956-961. 10.1136/thx.2005.040873, 1747227, 16131526.
21. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med 2003, 31:1250-1256. 10.1097/01.CCM.0000050454.01978.3B, 12682500.
22. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 44:837-845. 10.2307/2531595, 3203132.
23. Pencina MJ, D'Agostino RB, D'Agostino RB, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008, 27:157-172. discussion 207-112, 10.1002/sim.2929, 17569110.
24. Quinlan DJ, McQuillan A, Eikelboom JW. Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta-analysis of randomized, controlled trials. Ann Intern Med 2004, 140:175-183. 10.7326/0003-4819-140-3-200402030-00008, 14757615.
25. Quiroz R, Kucher N, Schoepf UJ, Kipfmueller F, Solomon SD, Costello P, Goldhaber SZ. Right ventricular enlargement on chest computed tomography: prognostic role in acute pulmonary embolism. Circulation 2004, 109:2401-2404. 10.1161/01.CIR.0000129302.90476.BC, 15148278.
26. Choi WI, Lee MY, Oh D, Rho BH, Hales CA. Estimated incidence of acute pulmonary embolism in a Korean hospital. Clin Appl Thromb Hemost 2011, 17:297-301. 10.1177/1076029610368669, 20530053.
27. Massberg S, Grahl L, von Bruehl ML, Manukyan D, Pfeiler S, Goosmann C, Brinkmann V, Lorenz M, Bidzhekov K, Khandagale AB, et al. Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat Med 2010, 16:887-896. 10.1038/nm.2184, 20676107.
28. Sanchez O, Trinquart L, Caille V, Couturaud F, Pacouret G, Meneveau N, Verschuren F, Roy PM, Parent F, Righini M, et al. Prognostic factors for pulmonary embolism: the prep study, a prospective multicenter cohort study. Am J Respir Crit Care Med 2010, 181:168-173. 10.1164/rccm.200906-0970OC, 19910608.
29. Scagliotti GV, Parikh P, von Pawel J, Biesma B, Vansteenkiste J, Manegold C, Serwatowski P, Gatzemeier U, Digumarti R, Zukin M, et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 2008, 26:3543-3551. 10.1200/JCO.2007.15.0375, 18506025.
30. Brenner H, Gondos A, Arndt V. Recent major progress in long-term cancer patient survival disclosed by modeled period analysis. J Clin Oncol 2007, 25:3274-3280. 10.1200/JCO.2007.11.3431, 17664474.
31. Gondos A, Bray F, Hakulinen T, Brenner H. Trends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis. Ann Oncol 2009, 20:564-573.
32. Huang CM, Lin YC, Lin YJ, Chang SL, Lo LW, Hu YF, Chiang CE, Wang KL, Chen SA. Risk stratification and clinical outcomes in patients with acute pulmonary embolism. Clin Biochem 2011, 44:1110-1115. 10.1016/j.clinbiochem.2011.06.077, 21723271.